We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Adopts International Guideline on Evaluating Carcinogenic Risk
EMA Adopts International Guideline on Evaluating Carcinogenic Risk
May 16, 2013
The European Medicines Agency (EMA) has joined the FDA in adopting draft international guidelines on identifying and mitigating impurities in drugs that use genotoxic or carcinogenic starting materials.